Home > Insider Trading > Filing (0001567619-21-004326)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219445	P Brian Mckeon	One Idexx Drive Westbrook ME 04092	Executive Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-14	810	$0.00	25,524	No	4	M	Direct
Common Stock	Acquisiton	2021-02-14	459	$0.00	25,983	No	4	M	Direct
Common Stock	Acquisiton	2021-02-14	505	$0.00	26,488	No	4	M	Direct
Common Stock	Acquisiton	2021-02-14	435	$0.00	26,923	No	4	M	Direct
Common Stock	Acquisiton	2021-02-14	433	$0.00	27,356	No	4	M	Direct
Common Stock	Disposition	2021-02-14	1,335	$544.08	26,021	No	4	F	Direct
Common Stock	Disposition	2021-02-16	1,307	$539.58	24,714	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right-to-buy)	Acquisiton	2021-02-14	9,538	$0.00	9,538	$544.08
Common Stock	Incentive Stock Option (right-to-buy)	Acquisiton	2021-02-14	183	$0.00	183	$544.08
Common Stock	Restricted Stock Unit	Acquisiton	2021-02-14	1,011	$0.00	1,011	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-02-14	810	$0.00	810	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-02-14	459	$0.00	459	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-02-14	505	$0.00	505	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-02-14	435	$0.00	435	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-02-14	433	$0.00	433	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,538	2031-02-13	No	4	A	Direct
183	2021-02-13	No	4	A	Direct
8,492		No	4	A	Direct
7,682		No	4	M	Direct
7,223		No	4	M	Direct
6,718		No	4	M	Direct
6,283		No	4	M	Direct
5,850		No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,050	Indirect	by Estony McKeon Family, LLC

Footnotes

Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
Not applicable.